BioNTech SE (BNTX) Announces 5M Share Proposed Public Offerings of ADSs and Rights Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to BioNTech SE (BNTX) Announces 5M Share Proposed Public Offerings of ADSs and Rights Offering

BioNTech SE (BNTX) files to offer 5 Million ADSs and 750K for selling shareholders

July 21, 2020 8:27 AM EDT

BioNTech SE (NASDAQ: BNTX) files to offer 5 Million ADSs and 750K for selling shareholders.

From the filing:

We are offering 5,000,000 American Depositary Shares,... More

BofA Securities Upgrades BioNTech (BNTX) to Buy as Positive Vaccine Updates Likely to Continue

July 21, 2020 4:19 AM EDT

(Updated - July 21, 2020 6:53 AM EDT)

(updated to add analyst comments)

BofA Securities analyst Tazeen Ahmad upgraded BioNTech (NASDAQ: BNTX) from Neutral to Buy with a price target of $105 (from $71), saying the company's vaccine program with Pfizer is starting to differentiate... More

Pfizer (PFE), BioNTech SE (BNTX) Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study

July 20, 2020 8:46 AM EDT

BioNTech SE (Nasdaq: BNTX) and Pfizer Inc. (NYSE: PFE) today announced initial data from their ongoing German Phase 1/2, open-label, non-randomized, non-placebo-controlled, dose-escalation trial, that is part of the global mRNA-based vaccine program against SARS-CoV-2. The data are... More